Relay Therapeutics, Inc.RLAYNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank57
3Y CAGR+1.5%
5Y CAGR+18.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+1.5%/yr
vs +56.7%/yr prior
5Y CAGR
+18.4%/yr
Recent deceleration
Acceleration
-55.2pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $314.54M | -17.8% |
| 2024 | $382.48M | -4.0% |
| 2023 | $398.55M | +32.6% |
| 2022 | $300.66M | -18.2% |
| 2021 | $367.73M | +172.6% |
| 2020 | $134.90M | +60.5% |
| 2019 | $84.05M | +68.5% |
| 2018 | $49.89M | - |